TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Randomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasectomy: ECOG-ACRIN E2810.

Leonard J Appleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.